$7.52
0.070.94%
At Close: -
$7.79
0.273.59%
After Hours: Jul 15, 6:05 PM EDT
15 minutes delayed
Comments
Loading...
Pieris Pharmaceuticals
PIRSNASDAQ
Pieris Pharmaceuticals (PIRS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPieris Pharmaceuticals (NASDAQ:PIRS) Stock Quotes, Forecast and News Summary
Pieris Pharmaceuticals Stock (NASDAQ: PIRS) stock price, news, charts, stock research, profile.
| Open | $7.49 |
| Close | $7.52 |
| Volume / Avg. | 43.90K / 20.80K |
| Day Range | 7.31 - 7.80 |
| 52 Wk Range | 6.20 - 41.78 |
| Market Cap | $10.28M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 1.68% |
| Days to Cover | 1.26 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Pieris Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the disco...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pieris Pharmaceuticals (PIRS) stock?
You can purchase shares of Pieris Pharmaceuticals (NASDAQ:PIRS) through any online brokerage.
Who are Pieris Pharmaceuticals (PIRS) competitors?
Other companies in Pieris Pharmaceuticals’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Addex Therapeutics (NASDAQ:ADXN), Coeptis Therapeutics (NASDAQ:COEP), Lumos Pharma (NASDAQ:LUMO) and Geovax Labs (NASDAQ:GOVX).
What is the target price for Pieris Pharmaceuticals (PIRS) stock?
There is no analysis for Pieris Pharmaceuticals.
What is the forecast for Pieris Pharmaceuticals (PIRS) stock?
There is no analysis for Pieris Pharmaceuticals to provide a consensus price target.
Current stock price for Pieris Pharmaceuticals (PIRS)?
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $7.79 last updated July 15, 2024 at 6:05 PM EDT.
Does Pieris Pharmaceuticals (PIRS) pay a dividend?
There are no upcoming dividends for Pieris Pharmaceuticals.
When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?
Pieris Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Pieris Pharmaceuticals (PIRS) going to split?
There is no upcoming split for Pieris Pharmaceuticals.
What sector and industry does Pieris Pharmaceuticals (PIRS) operate in?
Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.